GTF Chromium 200 mcg

GTF Chromium 200 mcg

NOW4.7 (127 ratings)
Format:Tablet Quantity: 250 Tablet(s) · 250 servings
Goals
$11.60 $0.04 per serving

Product analysis

72 out of 100

GTF Chromium 200 mcg offers economical chromium support for blood-sugar regulation. A reliable increase in calorie burning should not be expected from that role.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality60

Chromium is identified as an amino acid chelate, providing useful form detail. The preparation is a reasonable form choice without an established special advantage.

Ingredient Transparency80

The chromium amount and form are named, making the main ingredient easy to identify. The proportions within the declared source mixture remain unclear.

Value For Money100

The cost compares favorably for the declared amount of chromium. That supports its affordability for someone specifically seeking chromium.

Customer Satisfaction72

Customer ratings are generally positive, with a modest number of reviews. The limited review base leaves more uncertainty about how widely that satisfaction applies.

Product Focus49

The formula stays focused on chromium and its connection to blood-sugar regulation. That connection does not establish a dependable increase in metabolic rate or calorie burning.

Format
Tablet
Container
250 Tablet(s)
Per serving
$0.04
Customer rating
4.7 · 127 ratings
Report analysis

Goals

Impact
Moderate effect
B Ingredient FitF PathwaysC- EvidenceA+ Formulation Logic
Study evidence
Chromium Supportive 47 studies
Weight Loss
Impact
Lower effect
B Ingredient FitF PathwaysD- EvidenceA+ Formulation Logic
Study evidence
Chromium No effect 24 studies

Ingredients

IngredientAmount per servingScore
Chromium (Chromium Chelavite Amino Acid Chelate)
200 mcg 83
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
B- Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value
Each serving provides 200 mcg chromium; the cost for an equivalent 200 mcg is low. The chromium comes as Chromium Amino Acid Chelate. The chromium amount is stated, but a separate compound weight is not provided.
How this ingredient is rated

Active Ingredient Quality & Bioavailability72

The chromium comes as Chromium Amino Acid Chelate. A branded chromium source is indicated, though its name is not specified.
Chromium Chemical Form
The chromium comes as Chromium Amino Acid Chelate.
Branded & Trademarked Sources
A branded chromium source is indicated, though its name is not specified.

Dose, Safety & Label Transparency85

The serving provides 200 mcg chromium. The chromium amount is stated, but a separate compound weight is not provided.
Elemental Chromium Dosage
The serving provides 200 mcg chromium.
Label Transparency & Disclosure
The chromium amount is stated, but a separate compound weight is not provided.

Value100

The cost for an equivalent 200 mcg of chromium is low.
Price per 200 mcg Chromium
The cost for an equivalent 200 mcg of chromium is low.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
    Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J · Diabetes · 1997
    Randomized trial180 participantsMetabolism Support forChromium
  2. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z · Annals of nutrition & metabolism · 2016
    Randomized trial64 participantsMetabolism Support forChromium
  3. A Comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: A systematic review.
    Kooshki F; Tutunchi H; Vajdi M; Karimi A; Niazkar HR; Shoorei H; Pourghassem Gargari B · Clinical and experimental pharmacology & physiology · 2024
    Systematic review33 studies pooledMetabolism Support forChromium
  4. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y · PeerJ · 2023
    Meta-analysis2,362 participants41 studies pooledMetabolism Support forChromium
  5. [Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
    San Mauro-Martin I; Ruiz-León AM; Camina-Martín MA; Garicano-Vilar E; Collado-Yurrita L; Mateo-Silleras Bd; Redondo Del Río Mde P · Nutricion hospitalaria · 2017
    Meta-analysis13 studies pooledMetabolism Support forChromium
  6. The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.
    Farrokhian A; Mahmoodian M; Bahmani F; Amirani E; Shafabakhsh R; Asemi Z · Biological trace element research · 2021
    Randomized trial64 participantsWeight Loss forChromium
  7. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.
    Martin J; Wang ZQ; Zhang XH; Wachtel D; Volaufova J; Matthews DE; Cefalu WT · Diabetes care · 2006
    Randomized trial37 participantsWeight Loss forChromium
  8. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
    Ashoush S; Abou-Gamrah A; Bayoumy H; Othman N · The journal of obstetrics and gynaecology research · 2017
    Randomized trial100 participantsWeight Loss forChromium
  9. Chromium supplementation and polycystic ovary syndrome: A systematic review and meta-analysis.
    Fazelian S; Rouhani MH; Bank SS; Amani R · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2018
    Meta-analysis351 participants7 studies pooledWeight Loss forChromium
  10. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
    Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B · European journal of gastroenterology & hepatology · 2021
    Randomized trial46 participantsWeight Loss forChromium